PNU177836

PNU177836 is an experimental small molecule inhibitor belonging to the class of phenoxyacetic acid derivatives. It was designed as a highly specific inhibitor of protein-tyrosine phosphatase 1B (PTP1B), an enzyme that negatively regulates insulin signaling pathways. By inhibiting PTP1B, PNU177836 has been investigated for its potential to enhance insulin sensitivity and glucose uptake, making it a candidate for anti-diabetic therapy. Structural studies have confirmed its binding mode to the catalytic domain of human PTP1B, demonstrating remarkable specificity for this target[1][3][4]. The compound has not advanced beyond preclinical or early investigational stages and is not approved for any indication.